Shanghai Shyndec Pharmaceutical Co Ltd (600420) — Cash Flow-to-Debt Ratio
Shanghai Shyndec Pharmaceutical Co Ltd (600420) has a Cash Flow-to-Debt Ratio of 0.13x as of September 2025, meaning its operating cash flow of CN¥486.04 Million could theoretically repay 0% of its total liabilities (CN¥3.63 Billion) in one year. See Shanghai Shyndec Pharmaceutical Co Ltd leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shanghai Shyndec Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2004–2024)
Historical debt coverage capacity for Shanghai Shyndec Pharmaceutical Co Ltd across 21 annual periods. For the full cash flow conversion analysis, see Shanghai Shyndec Pharmaceutical Co Ltd (600420) cash conversion ratio.
Annual Cash Flow-to-Debt Ratio for Shanghai Shyndec Pharmaceutical Co Ltd (2004–2024)
Year-by-year debt coverage analysis for Shanghai Shyndec Pharmaceutical Co Ltd. Check 600420 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.49x | CN¥2.26 Billion | CN¥4.63 Billion | ▲ +41.9% |
| 2023 | 0.34x | CN¥1.72 Billion | CN¥5.01 Billion | ▼ -10.2% |
| 2022 | 0.38x | CN¥2.86 Billion | CN¥7.48 Billion | ▲ +97.8% |
| 2021 | 0.19x | CN¥1.68 Billion | CN¥8.70 Billion | ▲ +4.3% |
| 2020 | 0.19x | CN¥1.56 Billion | CN¥8.43 Billion | ▲ +22.9% |
| 2019 | 0.15x | CN¥1.27 Billion | CN¥8.44 Billion | ▼ -27.6% |
| 2018 | 0.21x | CN¥1.67 Billion | CN¥8.02 Billion | ▼ -32.4% |
| 2017 | 0.31x | CN¥2.31 Billion | CN¥7.52 Billion | ▲ +196.3% |
| 2016 | 0.10x | CN¥838.58 Million | CN¥8.08 Billion | ▲ +15.7% |
| 2015 | 0.09x | CN¥226.65 Million | CN¥2.53 Billion | ▼ -16.1% |
| 2014 | 0.11x | CN¥258.51 Million | CN¥2.42 Billion | ▼ -6.2% |
| 2013 | 0.11x | CN¥207.50 Million | CN¥1.82 Billion | ▼ -24.7% |
| 2012 | 0.15x | CN¥193.41 Million | CN¥1.28 Billion | ▼ -39.5% |
| 2011 | 0.25x | CN¥136.12 Million | CN¥544.70 Million | ▼ -35.3% |
| 2010 | 0.39x | CN¥115.11 Million | CN¥298.05 Million | ▼ -15.1% |
| 2009 | 0.45x | CN¥97.43 Million | CN¥214.24 Million | ▲ +28.0% |
| 2008 | 0.36x | CN¥58.04 Million | CN¥163.41 Million | ▼ -48.4% |
| 2007 | 0.69x | CN¥82.31 Million | CN¥119.57 Million | ▼ -19.4% |
| 2006 | 0.85x | CN¥73.60 Million | CN¥86.15 Million | ▲ +57.4% |
| 2005 | 0.54x | CN¥57.90 Million | CN¥106.67 Million | ▲ +137.0% |
| 2004 | 0.23x | CN¥17.02 Million | CN¥74.32 Million | — |